🇺🇸 FDA
Patent

US 9751932

Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 9751932 (Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61P, A61P1/16, A61P11/00